Overview
Your approach to running a decentralized clinical trial doesn’t have to be all or nothing. Decentralized clinical trials sit on a wide spectrum – they can be completely virtual, partially decentralized with hybrid approaches, or very similar to traditional “brick and mortar” trials.
Regardless of where your trial is on the decentralized spectrum, CTTI's recommendations can help you plan and conduct a successful trial.
Solutions
Search AllRecommendation Summary
Recommendations
Resources
- Clearing a Path for Broad Implementation of DCTs
- Considerations for Delivering an Investigational Product
Related Items
- Adoption of Decentralization: Are Our Perceptions Holding Us Back?
- CTTI Launches New Online Digital Health Trials Hub
- CTTI’s Digital Health Trials Hub: Revised Recommendations and New Resources for DCTs and Novel Endpoints
- Decentralized Clinical Trials Update Expert Meeting
- Adapting Clinical Trials during COVID-19: Solutions for Switching to Remote and Virtual Visits
- Legal, Regulatory, and Practical Issues to Consider When Adopting Decentralized Clinical Trials: Recommendations From the Clinical Trials Transformation Initiative
- CTTI Offers Path Forward for Using Decentralized Clinical Trials
- Conducting Multi-Center Trials: New Recommendations and Tool for Research
News
- CTTI Publication Explores Perceived Barriers and Recommendations Surrounding the Adoption of DecentralizationDespite widespread support for decentralization, real and perceived challenges remain, limiting wider implementation of decentralized elements. A new CTTI publication, published in the Journal of Therapeutic Innovation & Regulatory Science, ...